The client receiving a newly released medication is experiencing adverse effects.Why does the nurse report these adverse effects as part of the postmarketing surveillance stage of the drug approval process?

Question

Quizplus · Accepted Answer

Postmarketing surveillance is the stage of the drug approval process where harmful effects in the larger population continue to be monitored. This ensures that any adverse effects or safety concerns are caught and addressed as soon as possible. Individual client responses are not compared with clinical trial data in this stage, as the focus is on larger population data. The efficacy of the drug is determined in earlier stages, and while clinical trials may still be ongoing, they would not be collecting new data on adverse effects specifically.

The Client Receiving a Newly Released Medication Is Experiencing Adverse